Scoop has an Ethical Paywall
Oral Solid Dosage Pharmaceutical Formulation Market Set To Expand At 6.5% CAGR To Reach US$ 926.3 Billion During 2017-27
Future Market Insights (FMI), in its report, projects the global oral solid dosage pharmaceutical formulation market to register 6.5% CAGR during the forecast period 2017 to 2027. In terms of revenue, the market will reach nearly US$ 500,000 Mn in 2017; by 2027 is further estimated to surpass US$ 900,000 Mn.
Instead of increasing pipeline productivity for biologics and patent cliff challenges, oral solid dosage forms hold substantial opportunity in extending product lifecycle and leveraging growth potential. Manufacturers are employing various life cycle management patent strategies which include obtaining patents on isomers, metabolites, prodrugs, and new drug formulations such as extended, controlled, or rapid release formulations.
North America to Remain Largest Market for Oral Solid Dosage Pharmaceutical Formulation
North America will remain the largest market for oral solid dosage pharmaceutical formulation, followed by Asia Pacific Excluding Japan (APEJ) and Western Europe. Revenue from the market in North America is expected to surpass US$ 300,000 Mn by 2027-end. In addition, APEJ is projected to reach revenue worth US$ 294,750.4 Mn in the market by 2027. Latin America is expected to be the fastest growth region in the market, expanding at 9.2% CAGR through 2027. In contrast, Japan will witness a sluggish growth in the market.
Request for Report Sample @
http://www.futuremarketinsights.com/reports/sample/rep-gb-2782
By dosage form, tablets will continue to remain preferred in the market, with sales estimated to surpass US$ 500,000 Mn by 2027-end. Sales of tablets are anticipated to exhibit the highest CAGR in the market, followed by capsules. Capsules are expected to be the second most lucrative dosage form in the market, expanding at 6.1% CAGR through 2027.
Immediate Release to Remain Dominant in the Market during 2017-2027
Based on release mechanism, immediate release will remain dominant in the market, expanding at 6.4% CAGR through 2027. Immediate release is expected to generate revenue over US$ 400,000 Mn by 2027-end. Controlled release under extended release segment, is expected to register 7.4% CAGR through 2027.
Retail pharmacy is expected to be the largest end-user of oral solid dosage pharmaceutical formulation market by 2027-end. Retail pharmacy is expected to exhibit highest CAGR in the market through 2027. In contrast, Hospital pharmacy is expected to exhibit lowest CAGR, even though it stands as second largest end-user in the market during the forecast period.
Speak to our Research Expert @
https://www.futuremarketinsights.com/ask-question/rep-gb-2782
Increasing Presence of MNCs to Drive Market Growth in Latin America
Latin America is emerging as a manufacturing hub for oral solid dosage forms on the back of availability of low-cost resources. Multinational companies are focusing on expanding their presence in this region. These factors are expected to propel market growth in Latin America. Oral solid dosage forms are cost-effective and comparatively easy to manufacture than other dosage forms. They are most commonly used pharmaceuticals for treating various disease conditions in North America, which in turn is driving growth of the market in this region.
Growing effluent consumers in APEJ countries such as China, India and Korea are boosting growth of the oral solid dosage pharmaceutical formulation market in this region. Consumers here are adopting wealthy-life-fast-paced western lifestyle, leading them to suffer western lifestyle-related diseases including diabetes, cancer, and obesity. This compels them in seeking innovative drug treatments, which in turn is expected to fuel market growth in APEJ. However factors such as decreasing productivity of Asian manufacturers and containment issues, and low R&D expenditure coupled with challenges incurred in USFDA compliance are expected to impede growth of the market in APEJ.
Buy Now@ https://www.futuremarketinsights.com/checkout/2782
Key players identified in FMI's report include AstraZeneca Plc., Bristol-Myers Squibb Company, Eli Lilly and Company, Gilead Sciences, Merck & Co. Inc., Novartis AG, Pfizer Inc., AbbVie Inc., Boehringer Ingelheim GmbH, Hoffman-La-Roche Ltd., Johnson & Johnson, Biogen Inc., Bayer AG, Teva Pharmaceuticals, Amgen Inc., Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co., Ltd., Shire Plc., Celgene Corporation, Astellas Pharma Inc.
Explore FMI’s Extensive ongoing Coverage on Automotive Domain
Aseptic Formulation Processing Market - Aseptic formulation processing is the manipulation of sterile active pharmaceutical ingredient (APIs) or pharmaceutical product in a carefully controlled environment using aseptic technique in order to produce a sterile end product.
Oral Anticoagulants Market - Drug delivery via oral route is the gold standard in pharmaceutical market. Oral anticoagulants (normally called blood thinners) are drugs that collaborate with the body's regular blood-thickening framework to treat and anticipate unusual blood clots in the body.
Pharmaceutical Surfactants Market - Surfactants are commonly used in pharmaceuticals for recovery of intracellular products and gene delivery. Pharmaceutical surfactants can also be used as an antimicrobial agent.
Pharmaceutical Dosage Form Testing Systems Market - Pharmaceutical dosage form testing systems are used to verify the efficacy and bioavailability of a drug formulation. The evaluation and assessment of a tablet’s chemical, physical, and bioavailability properties are especially important in tablet design and for monitoring product quality.
Pharmaceutical Solid Dosage Contract Manufacturing Market - Pharmaceuticals solid dosage contract manufacturing is the largest segment of pharmaceutical formulations among in all type of pharmaceutical formulation outsourcing.
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/
Report: https://www.futuremarketinsights.com/reports/oral-solid-dosage-pharmaceutical-formulation-market
Future Market Insights
Future Market Insights is the premier provider of market intelligence and consulting services
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, UAE, and has its global delivery center in India. In addition to these, FMI also carries out business development and client engagement through its US and UK offices.
UN News: UN Teams Dispatch Aid As Deadly Flash Floods Hit Northern Afghanistan
Save The Children: It’s Not Safe And It’s Not Clean, But People Believe They Are Leaving Something Worse Behind
APEC: APEC Commits To Empowering People With Disabilities
UN News: Israeli Forces Bringing War To The West Bank, Warns UN Rights Office
UN News: 10,000 People Feared Buried Under The Rubble In Gaza
Save The Children: Heat-stricken Bangladesh Extends School Closures